Infection involves an attack of disease-causing agents such as bacteria and viruses on the host organism’s body that causes disturbances in normal functioning. Immunology is the study of the human body’s resistance to these infections. The combined study of infections and immunology would help authorities to handle infectious disease conditions including HIV, hepatitis, pneumonia, tuberculosis, malaria, inflammatory bowel diseases and autoimmune diseases. The infectious immunology market comprises of the diagnosis and treatment of these infectious diseases with the help of antigen antibody reactions.

The market is mainly driven by the significant applications of Infectious Immunology in various end use industries. The expanding demands from the HIV, TB, HBV and HCV and Pneumonia, are propelling Infectious Immunology market. Diagnostic Kits, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Instruments segment is estimated at % CAGR for the next seven-year period.

The global immunology market is gaining momentum due to the availability of various drugs approved by regulatory authorities and trends of improving clinical efficacy for new drug approvals. The high prevalence of immunological disorders further drives the market. The growing number of successful clinical trials due to environmental factors and the demand for biologics leads companies to invest in developing an affordable and effective imitation of biologic drugs and biosimilars. Furthermore, the ever-increasing cases of immunological diseases worldwide due to increasing geriatric populations and the adoption of sedentary lifestyles are pushing the market for growth. Additionally, the rising research and development activities in life sciences and biologics, including immunological drugs, will support market growth. Furthermore, the growing support from the governmental bodies and the approvals from the FDA for clinical trials are expected to enhance the market revenue from the governmental bodies and the approvals from the FDA for clinical trials are expected to enhance the market revenue.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Infectious Immunology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Infectious Immunology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Infectious Immunology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Infectious Immunology sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Infectious Immunology covered in this report include Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientifics, Bio-Rad Laboratories, Dr. Reddy’s Laboratories, AbbVie Inc, Janssen Global Services, Johnson & Johnson and Amgen Inc, etc.

The global Infectious Immunology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Abbott Laboratories

Roche Diagnostics

Thermo Fisher Scientifics

Bio-Rad Laboratories

Dr. Reddy’s Laboratories

AbbVie Inc

Janssen Global Services

Johnson & Johnson

Amgen Inc

Pfizer Inc

Novartis

Astellas

Bristol-Myers Squibb Company

Merck Sharp & Dohme Corp

UCB SA

Allergan

Scope of Infectious Immunology - Market Report

Report Metric	Details
Report Name	Infectious Immunology - Market
Forecasted market size in 2029	US$ 37790 million
CAGR	7.9%
Forecasted years	2023 - 2029
Global Infectious Immunology market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Infectious Immunology market, Segment by Type:	Diagnostic Kits Instruments Reagents
Global Infectious Immunology market, by Application	HIV TB HBV and HCV Pneumonia Malaria Inflammatory Bowel Diseases Auto Immune Diseases Others
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Infectious Immunology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Infectious Immunology - Market size in 2029?

Ans: The Infectious Immunology - Market size in 2029 will be US$ 37790 million.

What are the Application segmentation covered in the Infectious Immunology - Market report?

Ans: The Applications covered in the Infectious Immunology - Market report are HIV, TB, HBV and HCV, Pneumonia, Malaria, Inflammatory Bowel Diseases, Auto Immune Diseases, Others

What are the Type segmentation covered in the Infectious Immunology - Market report?

Ans: The Types covered in the Infectious Immunology - Market report are Diagnostic Kits, Instruments, Reagents

1 Market Overview of Infectious Immunology

1.1 Infectious Immunology Market Overview

1.1.1 Infectious Immunology Product Scope

1.1.2 Infectious Immunology Market Status and Outlook

1.2 Global Infectious Immunology Market Size Overview by Region 2018 VS 2022 VS 2029

1.3 Global Infectious Immunology Market Size by Region (2018-2029)

1.4 Global Infectious Immunology Historic Market Size by Region (2018-2023)

1.5 Global Infectious Immunology Market Size Forecast by Region (2024-2029)

1.6 Key Regions, Infectious Immunology Market Size (2018-2029)

1.6.1 North America Infectious Immunology Market Size (2018-2029)

1.6.2 Europe Infectious Immunology Market Size (2018-2029)

1.6.3 Asia-Pacific Infectious Immunology Market Size (2018-2029)

1.6.4 Latin America Infectious Immunology Market Size (2018-2029)

1.6.5 Middle East & Africa Infectious Immunology Market Size (2018-2029)

2 Infectious Immunology Market by Type

2.1 Introduction

2.1.1 Diagnostic Kits

2.1.2 Instruments

2.1.3 Reagents

2.2 Global Infectious Immunology Market Size by Type: 2018 VS 2022 VS 2029

2.2.1 Global Infectious Immunology Historic Market Size by Type (2018-2023)

2.2.2 Global Infectious Immunology Forecasted Market Size by Type (2024-2029)

2.3 Key Regions Market Size by Type

2.3.1 North America Infectious Immunology Revenue Breakdown by Type (2018-2029)

2.3.2 Europe Infectious Immunology Revenue Breakdown by Type (2018-2029)

2.3.3 Asia-Pacific Infectious Immunology Revenue Breakdown by Type (2018-2029)

2.3.4 Latin America Infectious Immunology Revenue Breakdown by Type (2018-2029)

2.3.5 Middle East and Africa Infectious Immunology Revenue Breakdown by Type (2018-2029)

3 Infectious Immunology Market Overview by Application

3.1 Introduction

3.1.1 HIV

3.1.2 TB

3.1.3 HBV and HCV

3.1.4 Pneumonia

3.1.5 Malaria

3.1.6 Inflammatory Bowel Diseases

3.1.7 Auto Immune Diseases

3.1.8 Others

3.2 Global Infectious Immunology Market Size by Application: 2018 VS 2022 VS 2029

3.2.1 Global Infectious Immunology Historic Market Size by Application (2018-2023)

3.2.2 Global Infectious Immunology Forecasted Market Size by Application (2024-2029)

3.3 Key Regions Market Size by Application

3.3.1 North America Infectious Immunology Revenue Breakdown by Application (2018-2029)

3.3.2 Europe Infectious Immunology Revenue Breakdown by Application (2018-2029)

3.3.3 Asia-Pacific Infectious Immunology Revenue Breakdown by Application (2018-2029)

3.3.4 Latin America Infectious Immunology Revenue Breakdown by Application (2018-2029)

3.3.5 Middle East and Africa Infectious Immunology Revenue Breakdown by Application (2018-2029)

4 Infectious Immunology Competition Analysis by Players

4.1 Global Infectious Immunology Market Size by Players (2018-2023)

4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Infectious Immunology as of 2022)

4.3 Date of Key Players Enter into Infectious Immunology Market

4.4 Global Top Players Infectious Immunology Headquarters and Area Served

4.5 Key Players Infectious Immunology Product Solution and Service

4.6 Competitive Status

4.6.1 Infectious Immunology Market Concentration Rate

4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

5.1 Abbott Laboratories

5.1.1 Abbott Laboratories Profile

5.1.2 Abbott Laboratories Main Business

5.1.3 Abbott Laboratories Infectious Immunology Products, Services and Solutions

5.1.4 Abbott Laboratories Infectious Immunology Revenue (US$ Million) & (2018-2023)

5.1.5 Abbott Laboratories Recent Developments

5.2 Roche Diagnostics

5.2.1 Roche Diagnostics Profile

5.2.2 Roche Diagnostics Main Business

5.2.3 Roche Diagnostics Infectious Immunology Products, Services and Solutions

5.2.4 Roche Diagnostics Infectious Immunology Revenue (US$ Million) & (2018-2023)

5.2.5 Roche Diagnostics Recent Developments

5.3 Thermo Fisher Scientifics

5.3.1 Thermo Fisher Scientifics Profile

5.3.2 Thermo Fisher Scientifics Main Business

5.3.3 Thermo Fisher Scientifics Infectious Immunology Products, Services and Solutions

5.3.4 Thermo Fisher Scientifics Infectious Immunology Revenue (US$ Million) & (2018-2023)

5.3.5 Bio-Rad Laboratories Recent Developments

5.4 Bio-Rad Laboratories

5.4.1 Bio-Rad Laboratories Profile

5.4.2 Bio-Rad Laboratories Main Business

5.4.3 Bio-Rad Laboratories Infectious Immunology Products, Services and Solutions

5.4.4 Bio-Rad Laboratories Infectious Immunology Revenue (US$ Million) & (2018-2023)

5.4.5 Bio-Rad Laboratories Recent Developments

5.5 Dr. Reddy’s Laboratories

5.5.1 Dr. Reddy’s Laboratories Profile

5.5.2 Dr. Reddy’s Laboratories Main Business

5.5.3 Dr. Reddy’s Laboratories Infectious Immunology Products, Services and Solutions

5.5.4 Dr. Reddy’s Laboratories Infectious Immunology Revenue (US$ Million) & (2018-2023)

5.5.5 Dr. Reddy’s Laboratories Recent Developments

5.6 AbbVie Inc

5.6.1 AbbVie Inc Profile

5.6.2 AbbVie Inc Main Business

5.6.3 AbbVie Inc Infectious Immunology Products, Services and Solutions

5.6.4 AbbVie Inc Infectious Immunology Revenue (US$ Million) & (2018-2023)

5.6.5 AbbVie Inc Recent Developments

5.7 Janssen Global Services

5.7.1 Janssen Global Services Profile

5.7.2 Janssen Global Services Main Business

5.7.3 Janssen Global Services Infectious Immunology Products, Services and Solutions

5.7.4 Janssen Global Services Infectious Immunology Revenue (US$ Million) & (2018-2023)

5.7.5 Janssen Global Services Recent Developments

5.8 Johnson & Johnson

5.8.1 Johnson & Johnson Profile

5.8.2 Johnson & Johnson Main Business

5.8.3 Johnson & Johnson Infectious Immunology Products, Services and Solutions

5.8.4 Johnson & Johnson Infectious Immunology Revenue (US$ Million) & (2018-2023)

5.8.5 Johnson & Johnson Recent Developments

5.9 Amgen Inc

5.9.1 Amgen Inc Profile

5.9.2 Amgen Inc Main Business

5.9.3 Amgen Inc Infectious Immunology Products, Services and Solutions

5.9.4 Amgen Inc Infectious Immunology Revenue (US$ Million) & (2018-2023)

5.9.5 Amgen Inc Recent Developments

5.10 Pfizer Inc

5.10.1 Pfizer Inc Profile

5.10.2 Pfizer Inc Main Business

5.10.3 Pfizer Inc Infectious Immunology Products, Services and Solutions

5.10.4 Pfizer Inc Infectious Immunology Revenue (US$ Million) & (2018-2023)

5.10.5 Pfizer Inc Recent Developments

5.11 Novartis

5.11.1 Novartis Profile

5.11.2 Novartis Main Business

5.11.3 Novartis Infectious Immunology Products, Services and Solutions

5.11.4 Novartis Infectious Immunology Revenue (US$ Million) & (2018-2023)

5.11.5 Novartis Recent Developments

5.12 Astellas

5.12.1 Astellas Profile

5.12.2 Astellas Main Business

5.12.3 Astellas Infectious Immunology Products, Services and Solutions

5.12.4 Astellas Infectious Immunology Revenue (US$ Million) & (2018-2023)

5.12.5 Astellas Recent Developments

5.13 Bristol-Myers Squibb Company

5.13.1 Bristol-Myers Squibb Company Profile

5.13.2 Bristol-Myers Squibb Company Main Business

5.13.3 Bristol-Myers Squibb Company Infectious Immunology Products, Services and Solutions

5.13.4 Bristol-Myers Squibb Company Infectious Immunology Revenue (US$ Million) & (2018-2023)

5.13.5 Bristol-Myers Squibb Company Recent Developments

5.14 Merck Sharp & Dohme Corp

5.14.1 Merck Sharp & Dohme Corp Profile

5.14.2 Merck Sharp & Dohme Corp Main Business

5.14.3 Merck Sharp & Dohme Corp Infectious Immunology Products, Services and Solutions

5.14.4 Merck Sharp & Dohme Corp Infectious Immunology Revenue (US$ Million) & (2018-2023)

5.14.5 Merck Sharp & Dohme Corp Recent Developments

5.15 UCB SA

5.15.1 UCB SA Profile

5.15.2 UCB SA Main Business

5.15.3 UCB SA Infectious Immunology Products, Services and Solutions

5.15.4 UCB SA Infectious Immunology Revenue (US$ Million) & (2018-2023)

5.15.5 UCB SA Recent Developments

5.16 Allergan

5.16.1 Allergan Profile

5.16.2 Allergan Main Business

5.16.3 Allergan Infectious Immunology Products, Services and Solutions

5.16.4 Allergan Infectious Immunology Revenue (US$ Million) & (2018-2023)

5.16.5 Allergan Recent Developments

6 North America

6.1 North America Infectious Immunology Market Size by Country (2018-2029)

6.2 U.S.

6.3 Canada

7 Europe

7.1 Europe Infectious Immunology Market Size by Country (2018-2029)

7.2 Germany

7.3 France

7.4 U.K.

7.5 Italy

7.6 Russia

7.7 Nordic Countries

7.8 Rest of Europe

8 Asia-Pacific

8.1 Asia-Pacific Infectious Immunology Market Size by Region (2018-2029)

8.2 China

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

8.6 India

8.7 Australia

8.8 Rest of Asia-Pacific

9 Latin America

9.1 Latin America Infectious Immunology Market Size by Country (2018-2029)

9.2 Mexico

9.3 Brazil

9.4 Rest of Latin America

10 Middle East & Africa

10.1 Middle East & Africa Infectious Immunology Market Size by Country (2018-2029)

10.2 Turkey

10.3 Saudi Arabia

10.4 UAE

10.5 Rest of Middle East & Africa

11 Infectious Immunology Market Dynamics

11.1 Infectious Immunology Industry Trends

11.2 Infectious Immunology Market Drivers

11.3 Infectious Immunology Market Challenges

11.4 Infectious Immunology Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

FEATURED COMPANIES

Abbott Laboratories

Roche Diagnostics

Thermo Fisher Scientifics

Bio Rad Laboratories

Dr. Reddy’s Laboratories

AbbVie

Janssen Global Services

Bristol Myers Squibb Company

Merck Sharp& Dohme Corp

UCB SA

Allergan plc

List of Tables

Table 1. Global Market Infectious Immunology Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029

Table 2. Global Infectious Immunology Market Size by Region (2018-2023) & (US$ Million)

Table 3. Global Infectious Immunology Market Size Share by Region (2018-2023)

Table 4. Global Infectious Immunology Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 5. Global Infectious Immunology Forecasted Market Size Share by Region (2024-2029)

Table 6. Global Infectious Immunology Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029

Table 7. Global Infectious Immunology Market Size by Type (2018-2023) & (US$ Million)

Table 8. Global Infectious Immunology Revenue Market Share by Type (2018-2023)

Table 9. Global Infectious Immunology Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 10. Global Infectious Immunology Revenue Market Share by Type (2024-2029)

Table 11. North America Infectious Immunology Revenue by Type (2018-2023) & (US$ Million)

Table 12. North America Infectious Immunology Revenue by Type (2024-2029) & (US$ Million)

Table 13. Europe Infectious Immunology Revenue by Type (2018-2023) & (US$ Million)

Table 14. Europe Infectious Immunology Revenue by Type (2024-2029) & (US$ Million)

Table 15. Asia-Pacific Infectious Immunology Revenue by Type (2018-2023) & (US$ Million)

Table 16. Asia-Pacific Infectious Immunology Revenue by Type (2024-2029) & (US$ Million)

Table 17. Latin America Infectious Immunology Revenue by Type (2018-2023) & (US$ Million)

Table 18. Latin America Infectious Immunology Revenue by Type (2024-2029) & (US$ Million)

Table 19. Middle East and Africa Infectious Immunology Revenue by Type (2018-2023) & (US$ Million)

Table 20. Middle East and Africa Infectious Immunology Revenue by Type (2024-2029) & (US$ Million)

Table 21. Global Infectious Immunology Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029

Table 22. Global Infectious Immunology Market Size by Application (2018-2023) & (US$ Million)

Table 23. Global Infectious Immunology Revenue Market Share by Application (2018-2023)

Table 24. Global Infectious Immunology Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 25. Global Infectious Immunology Revenue Market Share by Application (2024-2029)

Table 26. North America Infectious Immunology Revenue by Application (2018-2023) & (US$ Million)

Table 27. North America Infectious Immunology Revenue by Application (2024-2029) & (US$ Million)

Table 28. Europe Infectious Immunology Revenue by Application (2018-2023) & (US$ Million)

Table 29. Europe Infectious Immunology Revenue by Application (2024-2029) & (US$ Million)

Table 30. Asia-Pacific Infectious Immunology Revenue by Application (2018-2023) & (US$ Million)

Table 31. Asia-Pacific Infectious Immunology Revenue by Application (2024-2029) & (US$ Million)

Table 32. Latin America Infectious Immunology Revenue by Application (2018-2023) & (US$ Million)

Table 33. Latin America Infectious Immunology Revenue by Application (2024-2029) & (US$ Million)

Table 34. Middle East and Africa Infectious Immunology Revenue by Application (2018-2023) & (US$ Million)

Table 35. Middle East and Africa Infectious Immunology Revenue by Application (2024-2029) & (US$ Million)

Table 36. Global Infectious Immunology Revenue (US$ Million) by Players (2018-2023)

Table 37. Global Infectious Immunology Revenue Market Share by Players (2018-2023)

Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Infectious Immunology as of 2022)

Table 39. Date of Key Players Enter into Infectious Immunology Market

Table 40. Global Infectious Immunology Key Players Headquarters and Area Served

Table 41. Infectious Immunology Product Solution and Service

Table 42. Global Infectious Immunology Players Market Concentration Ratio (CR5 and HHI)

Table 43. Mergers & Acquisitions, Expansion Plans

Table 44. Abbott Laboratories Basic Information List

Table 45. Abbott Laboratories Description and Business Overview

Table 46. Abbott Laboratories Infectious Immunology Products, Services and Solutions

Table 47. Revenue (US$ Million) in Infectious Immunology Business of Abbott Laboratories (2018-2023)

Table 48. Abbott Laboratories Recent Developments

Table 49. Roche Diagnostics Basic Information List

Table 50. Roche Diagnostics Description and Business Overview

Table 51. Roche Diagnostics Infectious Immunology Products, Services and Solutions

Table 52. Revenue (US$ Million) in Infectious Immunology Business of Roche Diagnostics (2018-2023)

Table 53. Roche Diagnostics Recent Developments

Table 54. Thermo Fisher Scientifics Basic Information List

Table 55. Thermo Fisher Scientifics Description and Business Overview

Table 56. Thermo Fisher Scientifics Infectious Immunology Products, Services and Solutions

Table 57. Revenue (US$ Million) in Infectious Immunology Business of Thermo Fisher Scientifics (2018-2023)

Table 58. Thermo Fisher Scientifics Recent Developments

Table 59. Bio-Rad Laboratories Basic Information List

Table 60. Bio-Rad Laboratories Description and Business Overview

Table 61. Bio-Rad Laboratories Infectious Immunology Products, Services and Solutions

Table 62. Revenue (US$ Million) in Infectious Immunology Business of Bio-Rad Laboratories (2018-2023)

Table 63. Bio-Rad Laboratories Recent Developments

Table 64. Dr. Reddy’s Laboratories Basic Information List

Table 65. Dr. Reddy’s Laboratories Description and Business Overview

Table 66. Dr. Reddy’s Laboratories Infectious Immunology Products, Services and Solutions

Table 67. Revenue (US$ Million) in Infectious Immunology Business of Dr. Reddy’s Laboratories (2018-2023)

Table 68. Dr. Reddy’s Laboratories Recent Developments

Table 69. AbbVie Inc Basic Information List

Table 70. AbbVie Inc Description and Business Overview

Table 71. AbbVie Inc Infectious Immunology Products, Services and Solutions

Table 72. Revenue (US$ Million) in Infectious Immunology Business of AbbVie Inc (2018-2023)

Table 73. AbbVie Inc Recent Developments

Table 74. Janssen Global Services Basic Information List

Table 75. Janssen Global Services Description and Business Overview

Table 76. Janssen Global Services Infectious Immunology Products, Services and Solutions

Table 77. Revenue (US$ Million) in Infectious Immunology Business of Janssen Global Services (2018-2023)

Table 78. Janssen Global Services Recent Developments

Table 79. Johnson & Johnson Basic Information List

Table 80. Johnson & Johnson Description and Business Overview

Table 81. Johnson & Johnson Infectious Immunology Products, Services and Solutions

Table 82. Revenue (US$ Million) in Infectious Immunology Business of Johnson & Johnson (2018-2023)

Table 83. Johnson & Johnson Recent Developments

Table 84. Amgen Inc Basic Information List

Table 85. Amgen Inc Description and Business Overview

Table 86. Amgen Inc Infectious Immunology Products, Services and Solutions

Table 87. Revenue (US$ Million) in Infectious Immunology Business of Amgen Inc (2018-2023)

Table 88. Amgen Inc Recent Developments

Table 89. Pfizer Inc Basic Information List

Table 90. Pfizer Inc Description and Business Overview

Table 91. Pfizer Inc Infectious Immunology Products, Services and Solutions

Table 92. Revenue (US$ Million) in Infectious Immunology Business of Pfizer Inc (2018-2023)

Table 93. Pfizer Inc Recent Developments

Table 94. Novartis Basic Information List

Table 95. Novartis Description and Business Overview

Table 96. Novartis Infectious Immunology Products, Services and Solutions

Table 97. Revenue (US$ Million) in Infectious Immunology Business of Novartis (2018-2023)

Table 98. Novartis Recent Developments

Table 99. Astellas Basic Information List

Table 100. Astellas Description and Business Overview

Table 101. Astellas Infectious Immunology Products, Services and Solutions

Table 102. Revenue (US$ Million) in Infectious Immunology Business of Astellas (2018-2023)

Table 103. Astellas Recent Developments

Table 104. Bristol-Myers Squibb Company Basic Information List

Table 105. Bristol-Myers Squibb Company Description and Business Overview

Table 106. Bristol-Myers Squibb Company Infectious Immunology Products, Services and Solutions

Table 107. Revenue (US$ Million) in Infectious Immunology Business of Bristol-Myers Squibb Company (2018-2023)

Table 108. Bristol-Myers Squibb Company Recent Developments

Table 109. Merck Sharp & Dohme Corp Basic Information List

Table 110. Merck Sharp & Dohme Corp Description and Business Overview

Table 111. Merck Sharp & Dohme Corp Infectious Immunology Products, Services and Solutions

Table 112. Revenue (US$ Million) in Infectious Immunology Business of Merck Sharp & Dohme Corp (2018-2023)

Table 113. Merck Sharp & Dohme Corp Recent Developments

Table 114. UCB SA Basic Information List

Table 115. UCB SA Description and Business Overview

Table 116. UCB SA Infectious Immunology Products, Services and Solutions

Table 117. Revenue (US$ Million) in Infectious Immunology Business of UCB SA (2018-2023)

Table 118. UCB SA Recent Developments

Table 119. Allergan Basic Information List

Table 120. Allergan Description and Business Overview

Table 121. Allergan Infectious Immunology Products, Services and Solutions

Table 122. Revenue (US$ Million) in Infectious Immunology Business of Allergan (2018-2023)

Table 123. Allergan Recent Developments

Table 124. North America Infectious Immunology Market Size by Country (2018-2023) & (US$ Million)

Table 125. North America Infectious Immunology Market Size by Country (2024-2029) & (US$ Million)

Table 126. Europe Infectious Immunology Market Size by Country (2018-2023) & (US$ Million)

Table 127. Europe Infectious Immunology Market Size by Country (2024-2029) & (US$ Million)

Table 128. Asia-Pacific Infectious Immunology Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 129. Asia-Pacific Infectious Immunology Market Size by Region (2018-2023) & (US$ Million)

Table 130. Asia-Pacific Infectious Immunology Market Size by Region (2024-2029) & (US$ Million)

Table 131. Asia-Pacific Infectious Immunology Market Share by Region (2018-2023)

Table 132. Asia-Pacific Infectious Immunology Market Share by Region (2024-2029)

Table 133. Latin America Infectious Immunology Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 134. Latin America Infectious Immunology Market Size by Country (2018-2023) & (US$ Million)

Table 135. Latin America Infectious Immunology Market Size by Country (2024-2029) & (US$ Million)

Table 136. Middle East & Africa Infectious Immunology Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 137. Middle East & Africa Infectious Immunology Market Size by Country (2018-2023) & (US$ Million)

Table 138. Middle East & Africa Infectious Immunology Market Size by Country (2024-2029) & (US$ Million)

Table 139. Infectious Immunology Market Trends

Table 140. Infectious Immunology Market Drivers

Table 141. Infectious Immunology Market Challenges

Table 142. Infectious Immunology Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Infectious Immunology Market Size Year-over-Year 2018-2029 & (US$ Million)

Figure 2. Global Infectious Immunology Market Size (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Infectious Immunology Market Share by Regions: 2022 VS 2029

Figure 4. Global Infectious Immunology Forecasted Market Size Share by Region (2024-2029)

Figure 5. North America Infectious Immunology Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 6. Europe Infectious Immunology Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 7. Asia-Pacific Infectious Immunology Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 8. Latin America Infectious Immunology Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 9. Middle East & Africa Infectious Immunology Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 10. Product Picture of Diagnostic Kits

Figure 11. Global Diagnostic Kits Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 12. Product Picture of Instruments

Figure 13. Global Instruments Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 14. Product Picture of Reagents

Figure 15. Global Reagents Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 16. Global Infectious Immunology Market Size Share by Type: 2022 & 2029

Figure 17. North America Infectious Immunology Revenue Market Share by Type (2018-2029)

Figure 18. Europe Infectious Immunology Revenue Market Share by Type (2018-2029)

Figure 19. Asia-Pacific Infectious Immunology Revenue Market Share by Type (2018-2029)

Figure 20. Latin America Infectious Immunology Revenue Market Share by Type (2018-2029)

Figure 21. Middle East and Africa Infectious Immunology Revenue Market Share by Type (2018-2029)

Figure 22. HIV Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 23. TB Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 24. HBV and HCV Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 25. Pneumonia Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 26. Malaria Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 27. Inflammatory Bowel Diseases Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 28. Auto Immune Diseases Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 29. Others Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 30. Global Infectious Immunology Market Size Share by Application: 2022 & 2029

Figure 31. North America Infectious Immunology Revenue Market Share by Application (2018-2029)

Figure 32. Europe Infectious Immunology Revenue Market Share by Application (2018-2029)

Figure 33. Asia-Pacific Infectious Immunology Revenue Market Share by Application (2018-2029)

Figure 34. Latin America Infectious Immunology Revenue Market Share by Application (2018-2029)

Figure 35. Middle East and Africa Infectious Immunology Revenue Market Share by Application (2018-2029)

Figure 36. Infectious Immunology Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 37. Global Top 5 and Top 10 Players Infectious Immunology Market Share in 2022

Figure 38. North America Infectious Immunology Market Share by Country (2018-2029)

Figure 39. U.S. Infectious Immunology Market Size (2018-2029) & (US$ Million)

Figure 40. Canada Infectious Immunology Market Size (2018-2029) & (US$ Million)

Figure 41. Germany Infectious Immunology Market Size (2018-2029) & (US$ Million)

Figure 42. France Infectious Immunology Market Size (2018-2029) & (US$ Million)

Figure 43. U.K. Infectious Immunology Market Size (2018-2029) & (US$ Million)

Figure 44. Italy Infectious Immunology Market Size (2018-2029) & (US$ Million)

Figure 45. Russia Infectious Immunology Market Size (2018-2029) & (US$ Million)

Figure 46. Nordic Countries Infectious Immunology Market Size (2018-2029) & (US$ Million)

Figure 47. Asia-Pacific Infectious Immunology Market Share by Region (2018-2029)

Figure 48. China Infectious Immunology Market Size (2018-2029) & (US$ Million)

Figure 49. Japan Infectious Immunology Market Size (2018-2029) & (US$ Million)

Figure 50. South Korea Infectious Immunology Market Size (2018-2029) & (US$ Million)

Figure 51. Southeast Asia Infectious Immunology Market Size (2018-2029) & (US$ Million)

Figure 52. India Infectious Immunology Market Size (2018-2029) & (US$ Million)

Figure 53. Australia Infectious Immunology Market Size (2018-2029) & (US$ Million)

Figure 54. Latin America Infectious Immunology Market Share by Country (2018-2029)

Figure 55. Mexico Infectious Immunology Market Size (2018-2029) & (US$ Million)

Figure 56. Brazil Infectious Immunology Market Size (2018-2029) & (US$ Million)

Figure 57. Middle East & Africa Infectious Immunology Market Share by Country (2018-2029)

Figure 58. Turkey Infectious Immunology Market Size (2018-2029) & (US$ Million)

Figure 59. Saudi Arabia Infectious Immunology Market Size (2018-2029) & (US$ Million)

Figure 60. UAE Infectious Immunology Market Size (2018-2029) & (US$ Million)

Figure 61. Bottom-up and Top-down Approaches for This Report

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions